Tech Company Financing Transactions
Intersect ENT Funding Round
Private investors participated in a $1 million Series C funding round for Intersect ENT. The round closed on 9/2/2011.
Transaction Overview
Company Name
Announced On
9/2/2011
Transaction Type
Venture Equity
Amount
$1,018,585
Round
Series C
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing-amended.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
1555 Adams Dr.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Intersect ENT's mission is to advance clinically proven therapy solutions that enable ear, nose, and throat (ENT) physicians to solve clinical challenges and improve the quality of life for patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas West
Chief Financial Officer
Randy Meier
Chief Operating Officer
Christine Kowalski
VP - General Counsel
David Lehman
VP - Human Resources
Gwen Carscadden
VP - Sales
Robert Binney
Browse more venture capital transactions:
Prev: 9/2/2011: Punchbowl Software venture capital transaction
Next: 9/2/2011: ShiftPlanning venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs